Response to “From Pittsburgh to Cleveland: NHBD Controversies and Bioethics” by George J. Agich (CQ Vol 8, No 3): 60 Minutes Sets the Record Straight

Cambridge Quarterly of Healthcare Ethics

Volumn 8, Issue 4, 1999, Pages 514-517

  Koughan, Frank ^a   Bogdanich, Walt ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; PHENTOLAMINE;

60 MINUTES (CBS NEWS TELEVISION PROGRAM); ARTICLE; BIOETHICS AND PROFESSIONAL ETHICS; CLEVELAND CLINIC FOUNDATION; DEATH AND EUTHANASIA; ETHICIST; HEALTH CARE AND PUBLIC HEALTH; HEART ARREST; HUMAN; INSTITUTE OF MEDICINE; MEDICAL ETHICS; METHODOLOGY; ORGAN PRESERVATION; PUBLISHING; TRANSPLANTATION; TREATMENT WITHDRAWAL; UNITED STATES;

60 MINUTES (CBS NEWS TELEVISION PROGRAM); BIOETHICS AND PROFESSIONAL ETHICS; CLEVELAND CLINIC FOUNDATION; DEATH AND EUTHANASIA; HEALTH CARE AND PUBLIC HEALTH; INSTITUTE OF MEDICINE;

ADRENERGIC ALPHA-ANTAGONISTS; ETHICISTS; ETHICS, MEDICAL; HEART ARREST; HUMANS; JOURNALISM; ORGAN PRESERVATION; PHENTOLAMINE; TISSUE AND ORGAN PROCUREMENT; UNITED STATES; WITHHOLDING TREATMENT;

EID: 0033191402     PISSN: 09631801     EISSN: 14692147     Source Type: Journal    
DOI: 10.1017/s0963180199004132     Document Type: Article

References (14)

1. Warren J. Sollinger highly critical of 60 Minutes segment on Non-Heart Beating Donors, fears impact on organ donation, Transplant News 1997 (May 28);7;(10):1–3.
2. Institute of Medicine. Non-Heart-Beating Organ Transplantation: Medical and Ethical Issues in Procurement. Washington, D.C.: National Academy Press, 1997.
3. See note 3, Institute of Medicine 1997:4.
4. The following analysis is taken directly from an unpublished paper written by John Clough, M.D., Cleveland Clinic Foundation, entitled “The Safety of Phentolamine.” I am entirely indebted to this paper for the details of this review.
5. Arnér S. Intravenous phentolamine test: diagnostic and prognostic use in reflex sympathetic dystrophy. Pain 1991;46:17–22.
6. Raja SN, Treede RD, Davis KD, Campbell JN. Systematic alpha-adrenergic blockade with phentolamine: a diagnostic test for sympathetically maintained pain. Anesthesiology 1991;74:691–698.
7. Shir Y, Cameron LB, Raja SN, Bourke DL. The safety of intravenous phentolamine administration in patients with neuropathic pain. Anesth Analg 1993;76:1008–1011.
8. Dellemijn PL, Fields HL, Allen RR, McKay WR, Rowbotham MC. The interpretation of pain relief and sensory changes following sympathetic blockade. Brain 1994;117:1475–1487.
9. Chatterjee K, Parmley WW. The role of vasodilatory therapy in heart failure. Prog Cardiovasc Dis 1977;19:301–325.
10. Korewicki J, Rajecka A, Pogorzelska H, Madeja G. Wplyw dozylnego podania nitro-gliceryny i regtyny na hemodynamike w niedomykalnosci mitralnej. Kardiol Pol 1990;33:365–374.
11. Kelly DT, Delgado CE, Taylor DR, Pitt B, Ross RS. Use of phentolamine in acute myo-cardial infarction associated with hypertension and left ventricular failure. Circulation 1973;47:729–735.
12. Perret C, Gardaz J-P, Reynaert M, Grimbert F, Enrico J.-F. Phentolamine for vasodilator therapy in left ventricular failure complicating acute myocardial infarction. British Heart Journal 1975;37:640–646.
13. Walinsky P, Chatterjee K, Forrester J, Parmley WW, Swan HJC. Enhanced left ventricular performance with phentolamine in acute myocardial infarction. American Journal of Cardiology 1974;33:37–41.
14. Gould L, Reddy CVR, Kalanithi P, Espina L, Gomprecht RF. Use of phentolamine in acute myocardial infarction. American Heart Journal 1974;88:144–148.